CNS Co.,Ltd
Fiscal Year Ending May 2027 Q1 Financial Summary
Net sales were 9,278 million yen (YoY +19.3%), and operating income was 966 million yen (YoY +40.9%), exceeding the prior-year results. AI-related projects performed strongly, led by Technology Solutions. The full-year forecast is unchanged from the previous disclosure; Q1 profits exceeded expectations due to lower-than-expected SG&A expenses. ERP implementation delays remain but are expected to contribute from Q3 onward. The company will continue a progressive dividend policy targeting a payout ratio of 30% or more. Note that Q1 results and full-year forecasts are primarily compared to the fiscal year ended May 2026 results.
Key Figures
- Net Sales: 9,278 million yen (YoY +19.3%)
- Operating Income: 966 million yen (YoY +40.9%)
- Dividend per Share: Forecast/actual values are referenced in the text, but specific amounts are unknown in the PDF excerpt and therefore treated as Unknown
AI要約
Performance Overview
Consolidated results for Q1 of the fiscal year ending May 2027 recorded net sales of 9,278 million yen, up 19.3% year-on-year, and operating income of 966 million yen, up 40.9% year-on-year, achieving significant profit growth. Technology Solutions was driven by strong AI projects, contributing high-value-added projects with improved service efficiency. Consulting showed signs of recovery in project orders but was impacted by ERP implementation delays. Some SG&A expenses were below expectations, causing profits to exceed forecasts.
Outlook and Capital Policy
The full-year outlook for the fiscal year ending May 2027 remains as previously announced, with profits expected to be concentrated in the second half. The company will expand enterprise-wide deployment of generative AI to grow prime projects. It aims for medium-term growth by strengthening the ERP business and alliances. As a capital strategy, growth investments will be prioritized while maintaining a progressive dividend policy targeting a payout ratio of 30% or more, balancing internal reserves with improved capital efficiency.
CNS Co.,Ltd
Company overview · Stock price · Financial data · All IR
